Clinical Trial Update: Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating ganetespib with platinum in malignant pleural mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• Ganetespib (ganetespib)

Snippet

Sponsor: University College, London | Conditions: Lung Cancer - Malignant Pleural Mesothelioma | Phase 1, Phase 2 | Status: COMPLETED